Status:
COMPLETED
A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander
Lead Sponsor:
Northwell Health
Conditions:
Autism Spectrum Disorder
Wandering Behavior
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot study will obtain preliminary data about the impact of wearable electronic tracking devices (ETDs) as an intervention for children with autism spectrum disorders (ASD) who wander. The feasi...
Detailed Description
Wandering, or elopement, is a life-threatening behavior that has been reported to occur in a third of all children with autism spectrum disorders (ASD). Wearable electronic tracking devices (ETDs) tha...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Parent of a child between the ages of 4 and 17 who currently has autism spectrum disorder (ASD), was diagnosed with ASD by a professional, and has wandered at least once in the preceding 3 months
- Currently lives in the United States
- Currently lives with child with ASD
- Has been living with child with ASD for at least 6 months
- Has reliable internet access to allow for completion of online questionnaires
Exclusion
- Current or past use of any electronic tracking device to address wandering behavior in the child with ASD
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2019
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03814902
Start Date
January 15 2019
End Date
November 11 2019
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cohen Children's Medical Center of New York
New Hyde Park, New York, United States, 11042